PANCREATIC PDTX CANCER MODELS AVAILABLE:

Pancreatic cancer and liver cancer are the only cancers for which incidence and death rates have been increasing. Most patients diagnosed with pancreatic cancer are in advanced stages of disease making treatment a challenge.

Unfortunately, the current treatment strategies are not effective for patients with advanced disease. Therefore, an urgent need exists for novel therapies and animal models for testing response to new therapies.

Request pancreatic cancer xenograft study quote from Altogen Labs CRO.

Tumor Model	Mutation
Pancreatic Carcinoma	KRAS(G12A), MPL
	TP53, KIT, GNA11
Ductal Carcinoma
Adenosquamous Carcinoma
Invasive Pancreatic Ductal Adenocarcinoma	TP53
Metastatic Pancreatic Carcinoma	KRAS,
Cholangiocarcinoma
Ampullary Cancer